Log In
BCIQ
Print this Print this
 

Effi-7 (formerly MD707)

  Manage Alerts
Collapse Summary General Information
Company OSE Immunotherapeutics S.A.
DescriptionHumanized mAb targeting interleukin-7 (IL-7) receptor (CD127)
Molecular Target Interleukin-7 (IL-7) receptor (CD127)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$33.7M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/31/2016

$33.7M

0

0

Get a free BioCentury trial today